SUNMO, Bispecifics, and a New Standard for Relapsed/Refractory Large B-Cell Lymphoma
In a Pharmacy Times interview, Elizabeth Budde, MD, executive medical director of the Enterprise Immune Effector Cell Program and associate professor in hematology at City of Hope, discusses the phase 3 data behind the mosunetuzumab (Lunsumio; Genentech, Inc) plus polatuzumab vedotin (Polivy; Genentech) combination, what grade 1 CRS actually looks like at the bedside, and why she believes a subset of patients treated with bispecific-based regimens may ultimately be cured. You can find more expert insights at PharmacyTimes.com, where we provide pharmacy news, clinical insights, & continuing education to help pharmacists deliver drug expertise & accessible patient care. Original Interview: Visit Pharmacy Times: https://www.pharmacytimes.com/ Follow Pharmacy Times on social media! X: @Pharmacy_Times Facebook: Pharmacy Times LinkedIn: Pharmacy Times BlueSky: @PharmacyTimes.bsky.social TikTok: @pharmacytimes #pharmacy #politics #pharma #pharmacist
Seniors No 1 Oncologist Reveals Foods to Starve Cancer Cells Naturally After 50! |Dr. William Li
The Future of Localized Prostate Cancer Treatment: Mary-Ellen Taplin, MD, and the PROTEUS Trial
Ukraine's drone war is isolating Crimea
Sarah Paine - Why Putin and Xi can't escape geography
Colin Farrell Opens Up About His Son With Angelman Syndrome | PEOPLE
ASCO 2026: GLP-1 Receptor Agonists May Reduce Mortality in Patients With Cancer
System Design Course – APIs, Databases, Caching, CDNs, Load Balancing & Production Infra
Trump Gets Booed & Falls Asleep During NBA Finals, Claims War is Almost Over & Goodbye Spencer Pratt
Ivermectin to Treat Cancer? Get the FACTS
The Weekly Dose: TrumpRx Expansion, Hepatitis B Vaccination Gaps, and New FDA Approvals
Did One Tiny Tweak Just Solve Heart Disease?
The French Do Not Care About Work
Incredible Process of 24k Pure Gold Extraction From Old PC RAM | How to Make Gold Into RAM
Golden Retriever Meets Completely Broken Rescue for the First Time
💔 HEARTBREAKING: Michael Bennett's Soul-Stirring "After I'm Gone" Performance!
Wie funktioniert die CAR-T-Zelltherapie
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis
The new medical innovations that could change everything - The Engineers, BBC World Service
Nobody Breaks Celebrities Like Rowan Atkinson
